StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories diagnostic Products — Segment Depreciation & Amortization ($M) ($M)

Postgres DB segment_values + Form 10-K/10-Q XBRL

QuarterlyAnnual
Latest, Q2 2026
165
Period ended Jun 30, 2026
Change on a year earlier
+22.2%
135 in Q2 2025
History
10 quarters
Since Q1 2024
Sources
6
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiagnostic Products — Segment Depreciation & Amortization ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026165+22.2%SEC Filing (0001628280-26-050134) ↗
Q1 2026Mar 31, 2026144+14.3%SEC Filing (0001628280-26-028357) ↗
Q4 2025Dec 31, 2025136+1.5%SEC Filing (0001628280-26-010185) ↗
Q3 2025Sep 30, 2025136+5.4%SEC Filing (0001628280-25-047131) ↗
Q2 2025Jun 30, 2025135+4.7%SEC Filing (0001628280-26-050134) ↗
Q1 2025Mar 31, 2025126-2.3%SEC Filing (0001628280-26-028357) ↗
Q4 2024Dec 31, 2024134–SEC Filing (0001628280-26-010185) ↗
Q3 2024Sep 30, 2024129–SEC Filing (0001628280-25-047131) ↗
Q2 2024Jun 30, 2024129–SEC Filing (0001628280-25-036720) ↗
Q1 2024Mar 31, 2024129–SEC Filing (0001628280-25-021090) ↗

Cite this data

StockData. (2026). Abbott Laboratories Diagnostic Products — Segment Depreciation & Amortization ($M) ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-seg-depr-dx

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.